Vijayakrishna K. Gadi, M.D. PHD
NPI 1053358671ActiveIndividual· Internal Medicine, Medical Oncology· Seattle, WA
Internal Medicine, Medical Oncology (M.D. PHD) in Seattle, Washington, trained at University of Alabama School of Medicine (class of 2000). Their prescriptions cost Medicare Part D more than their services did: $348,679 for 95 claims, against $4,431 paid for services in 2024. Gilead Sciences, Inc. was the largest of 11 companies reporting payments in 2025, $69,804 in all, mostly consulting fees.
Overview
| NPI | 1053358671 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. PHD |
| Sole proprietor | No |
| NPI issued | Jun 1, 2006 |
| Last updated in NPPES | Mar 5, 2025 |
| Certified by provider | Mar 5, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | 036151951 | IL |
| Internal Medicine, Hematology & Oncology | 207RH0003X | 036151951 | IL |
| Internal Medicine, Medical Oncology | 207RX0202X | MD00041517 | WA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (IL) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 23 |
|---|---|
| Services billed | 60 across 10 procedure codes |
| Paid by Medicare | $4,431 |
Part D prescriptions in 2024
| Prescriptions (claims) | 95 · 146 30-day fills |
|---|---|
| Patients | 27 |
| Total drug cost | $348,679 |
| Generic share | 75% of claims |
Education and affiliations
| Medical school | University of Alabama School of Medicine |
|---|---|
| Graduation year | 2000 |
| Medicare specialty | Medical Oncology |
Medical group
- The Board of Trustees of the University of IllinoisChicago, IL · 1,150 clinicians
Hospital affiliation
- University of Illinois Hospital and ClinicsChicago, IL
Industry payments (Open Payments)
- 2025$69,804 · 85 payments from 11 companies
- 2024$106,019 · 98 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Gilead Sciences, Inc. | $20,340 | 27 |
| Puma Biotechnology, Inc. | $16,324 | 10 |
| Astrazeneca Pharmaceuticals LP | $10,618 | 8 |
| Pfizer Inc. | $6,802 | 10 |
| Novartis Pharmaceuticals Corporation | $6,534 | 9 |
What the 2025 payments were for
- Consulting Fee$60,970 · 21 payments
- Travel and Lodging$6,066 · 21 payments
- Food and Beverage$2,753 · 42 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$14.40 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Medical Oncology providers in Seattle
- 1174849855
- 1003171976
- 1356426183
- 1932285731
- 1962777862
- 1255523775
- 1992912224
- 1225041791
- 1073695227
- 1902366677
- 1992880991
- 1265576656
All Internal Medicine, Medical Oncology providers in Washington →